在高移民环境中短期结核病预防疗法:伊利诺伊州库克县的1HP早期经验
Samuel Starke1,2, Keziah Thomas3, Supriya Jasuja3
1Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, USA.
概括
一个新的为期一个月的结核病预防疗法表现出良好的耐受性和与标准治疗相似的完成率. 这对于改善非美国出生人口的结核病控制至关重要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,特别是在非美国出生的人口中.
- 潜在结核病感染 (LTBI) 治疗对于预防结核病至关重要,但治疗完成率可能不够理想.
- 卫生部门在为各种客户群体提供有效的LTBI治疗方面面临挑战.
研究的目的:
- 为了评估一种新的1个月的异化-利法丁 (1HP) 治疗潜伏结核病感染的疗程的有效性和耐受性.
- 评估一项美国卫生部计划中的结核病预防治疗启动和完成率,该计划主要为非美国出生的客户提供服务.
- 为了比较1HP方案和传统方案之间的治疗完成.
主要方法:
- 美国卫生部结核病计划数据的回顾性分析.
- 评估患者启动和完成结核病预防治疗的情况.
- 一个月的1HP疗程与标准持续时间疗程的完成率的比较.
主要成果:
- 78%的被评估患者开始了结核病预防治疗.
- 整体治疗完成率为71%.
- 新到达的移民中完成率较低,但1HP疗法表现出良好的耐受性和与传统疗法相比的完成率.
结论:
- 一个月的异化-利法丁治疗方案是潜在结核病感染治疗的良好耐受和有效选择.
- 需要制定改善治疗完成率的策略,特别是在新抵达的移民中.
- 这种方案提供了一种有希望的方法,以提高高风险人群的结核病预防治疗完成率.
相关概念视频
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
362
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
362
Cancer Prevention
7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.7K
Gene Therapy
27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Pulmonary Tuberculosis I
869
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
869
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis V
550
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
550


